Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Imaging, Diagnosis, Prognosis

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer

Jennifer M. Specht, Brenda F. Kurland, Susan K. Montgomery, Lisa K. Dunnwald, Robert K. Doot, Julie R. Gralow, Georgina K. Ellis, Hannah M. Linden, Robert B. Livingston, Kimberly H. Allison, Erin K. Schubert and David A. Mankoff
Jennifer M. Specht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda F. Kurland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan K. Montgomery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa K. Dunnwald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert K. Doot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie R. Gralow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgina K. Ellis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah M. Linden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert B. Livingston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly H. Allison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin K. Schubert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Mankoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-10-0026 Published May 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    MRFDG (μmol/min/100 g) by subtype using box and whisker plots. □, data points.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    BF (mL/min/g) by subtype using box and whisker plots. □, data points.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    MRFDG/BF ratio by subtype using box and whisker plots. □, data points.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    MRFDG (μmol/min/100 g) and BF (mL/min/g) for each subtype. Light shaded symbols, nonresponders; dark shaded symbols, patients who achieved pCR. •, pCR in TN tumors; ▪, pCR in HER2 tumors; ▴, pCR in luminal tumors.

Tables

  • Figures
  • Table 1.

    Selected characteristics among patients with LABC

    CharacteristicsNo. of patients (n = 71)%
    Age, y
        <401927
        40-492535
        50-591927
        ≥60811
    Race
        Non-Hispanic white5679
        African-American913
        Asian/Pacific Islander68
    Histology
        Ductal6592
        Lobular68
    Clinical tumor classification
        T134
        T21420
        T34158
        T41318
    Clinical lymph node classification
        N01521
        N14361
        N21115
        N323
    Tumor size, cm
        0-1.957
        2.0-53549
        >53144
    Ki-67 proliferative index*
        Low or intermediate (≤20%)1626
        High (>20%)4574
    Menopausal status
        Pre4766
        Post2434
    Tumor grade
        157
        22231
        34462
    Breast cancer subtype (by IHC)
        TN2535
        HER268
        Luminal4056
    • ↵*Unknown, n = 10.

  • Table 2.

    Tumor characteristics and PET parameters by subtype

    CharacteristicsTN (n = 25)HER2 (n = 6)Luminal n = 40P global difference by subtype*Odds ratio, P TN vs luminal†
    Tumor grade
        3 (vs 1 or 2)‡22 (88%)4 (67%)18 (45%)8.7
        95% CI§(70%, 96%)(30%, 90%)(31%, 60%)0.001<0.001
    Ki-67 proliferative index∥
        High (vs low or intermediate)20 (95%)3 (60%)22 (63%)0.0111.4
        95% CI§(77%, 100%)(23%, 88%)(46%, 77%)0.009
    PCR
        pCR (vs no or partial response) 7 (28%)4 (67%)5 (13%)0.0142.7
        95% CI§(14%, 48%)(30%, 90%)(5%, 26%)0.188
    MRFDG, μmol/min/100 g
        Mean15.97.589.720.0090.019
        SD10.45.317.8
    BF, mL/min/g
        Mean0.3540.3150.3520.7310.773
        SD0.1480.1290.214
    MRFDG: BF ratio
        Mean44.324.128.70.0040.011
        SD2314.614.6
    • ↵*Fisher's exact test for grade, Ki-67, pCR; likelihood ratio test for PET.

    • ↵†Odds ratio and Fisher's exact test P value for grade, Ki-67, and pCR; Tukey-Kramer test for PET (difference not given for log-transformed variables).

    • ↵‡Five luminal tumors were grade 1; others were grade 2.

    • ↵§CIs computed using Wilson (score) method.

    • ↵∥Missing values, n = 4 (TN), n = 1 (Her2), and n = 5 (luminal).

PreviousNext
Back to top
Clinical Cancer Research: 16 (10)
May 2010
Volume 16, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer
Jennifer M. Specht, Brenda F. Kurland, Susan K. Montgomery, Lisa K. Dunnwald, Robert K. Doot, Julie R. Gralow, Georgina K. Ellis, Hannah M. Linden, Robert B. Livingston, Kimberly H. Allison, Erin K. Schubert and David A. Mankoff
Clin Cancer Res May 15 2010 (16) (10) 2803-2810; DOI: 10.1158/1078-0432.CCR-10-0026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer
Jennifer M. Specht, Brenda F. Kurland, Susan K. Montgomery, Lisa K. Dunnwald, Robert K. Doot, Julie R. Gralow, Georgina K. Ellis, Hannah M. Linden, Robert B. Livingston, Kimberly H. Allison, Erin K. Schubert and David A. Mankoff
Clin Cancer Res May 15 2010 (16) (10) 2803-2810; DOI: 10.1158/1078-0432.CCR-10-0026
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • FDOPA PET Survival Predictions for Glioma
  • In vivo Fluorescence Lifetime Imaging for Monitoring the Cancer Treatment
  • Variability in Assessing Response in Metastatic Colorectal Cancer
Show more Imaging, Diagnosis, Prognosis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement